2024/03/28 17:32:21 | |
---|---|
Price | |
50.20 EUR | |
Difference | 2.55% (1.25) |
ISIN | US1101221083 |
Symbol | BMY |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 102,258 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 50.20 EUR |
High | 50.20 EUR |
Low | 50.20 EUR |
Close (prev. day) | 48.95 EUR |
VWAP | 48.15 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
Related Futures | 15 |
Related Options | - |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 17:32:21 | |
---|---|
Price | |
50.20 EUR | |
Difference | 2.55% (1.25) |
ISIN | US1101221083 |
Symbol | BMY |
Exchange | Vienna Stock Exchange |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 102,258 EUR |
Benchmark | S&P 500 |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 50.20 EUR |
High | 50.20 EUR |
Low | 50.20 EUR |
Close (prev. day) | 48.95 EUR |
VWAP | 48.15 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 1 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | -9.22% | -20.42% | -7.14% |
Perf (abs.) | -5.10 | -12.88 | -3.86 |
Beta | 0.59 | 0.45 | 0.31 |
Volatility | 25.12 | 21.61 | 20.94 |
Ø price 5 days | Ø volume 5 days (pcs.) | 48.72 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 47.86 EUR (8) |
Ø price 100 days | Ø volume 100 days (pcs.) | 46.76 EUR (19) |
Ø price 250 days | Ø volume 250 days (pcs.) | 53.33 EUR (10) |
YTD High | date | 50.20 EUR (2024/03/28) |
YTD Low | date | 44.50 EUR (2024/02/06) |
52 Weeks High | date | 64.70 EUR (2023/04/06) |
52 Weeks Low | date | 44.50 EUR (2024/02/06) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
BX Swiss | 2024/02/21 | 18:00 | 44.08 CHF | 0.01 | 1 |
Berlin | 2024/03/28 | 15:26 | 49.70 EUR | 0.00 | 2 |
Duesseldorf | 2024/03/28 | 19:30 | 50.10 EUR | 0.00 | 7 |
Euronext Milan MTF Global Equity Market | 2024/03/28 | 17:44 | 50.10 EUR | 0.00 | 1 |
Euronext Milan MTF Trading After Hours | 2024/02/28 | 18:52 | 46.90 EUR | 0.00 | 1 |
Frankfurt | 2024/03/28 | 21:07 | 50.00 EUR | 0.04 | 6 |
Hamburg | 2024/03/28 | 08:10 | 49.10 EUR | 0.00 | 1 |
Hanover | 2024/03/28 | 08:36 | 49.15 EUR | 0.00 | 3 |
London Stock Exchange European Trade Reporting | 2024/03/28 | 17:30 | 53.05 USD | 0.03 | 7 |
Munich | 2024/03/28 | 08:05 | 49.05 EUR | 0.00 | 1 |
NYSE | 2024/03/28 | 21:00 | 54.23 USD | 777.02 | 99,624 |
SIX Swiss Exchange | 2019/07/03 | 05:55 | 45.30 USD | 0.00 | 1 |
SIX Swiss Exchange | 2019/06/28 | 17:35 | 44.39 CHF | 0.00 | 1 |
Stuttgart | 2024/03/28 | 19:28 | 50.40 EUR | 0.05 | 13 |
Tradegate | 2024/03/28 | 22:26 | 50.10 EUR | 0.68 | 105 |
Vienna Stock Exchange | 2024/03/28 | 17:32 | 50.20 EUR | 0.00 | 1 |
Xetra | 2024/03/28 | 17:35 | 50.10 EUR | 0.15 | 39 |
BRISTOL MYERS SQUIBB CO. |
- - |
Route 206 & Province Line Road - 08543 Princeton |
Telefon: +1-609-252-4621 |
Fax: + |
E-mail: - |
Bristol Myers Squibb Co. engages in the discovery, development, licensing, manufacture, marketing, distribution, and sale of biopharmaceutical products. It offers small molecules, products produced from biological processes called biologics, and chimeric antigen receptor (CAR-T) cell therapies. The company was founded in August 1933 and is headquartered in Princeton, NJ. |
Giovanni Caforio | Chairman of Board of Directors |
Deepak Bhatt | Member of Board of Directors |
Julia Haller | Member of Board of Directors |
Karen Vousden | Member of Board of Directors |
Manuel Hidalgo Medina | Member of Board of Directors |
Derica Rice | Member of Board of Directors |
Gerald Storch | Member of Board of Directors |
Paula Price | Member of Board of Directors |
Peter Arduini | Member of Board of Directors |
Phyllis Yale | Member of Board of Directors |
Theodore Samuels | Member of Board of Directors |
Giovanni Caforio | Chairman of Managing Board |
Christopher Boerner | Member of Executive Committee |
Adam Dubow | Member of Executive Committee |
Ann M. Powell | Member of Executive Committee |
Catalina Vargas | Member of Executive Committee |
David Elkins | Member of Executive Committee |
Elizabeth A. Mily | Member of Executive Committee |
Lou Schmukler | Member of Executive Committee |
Michelle Weese | Member of Executive Committee |
Paul von Autenried | Member of Executive Committee |
Rupert Vessey | Member of Executive Committee |
Samit Hirawat | Member of Executive Committee |
Sandra Leung | Member of Executive Committee |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer